Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 9, 2008, Pages 911-920

  Snuderl, Matija ^a   Chi, Susan N ^b   De Santis, Stacia M ^c   Stemmer Rachamimov, Anat O ^a   Betensky, Rebecca A ^c   De Girolami, Umberto ^b   Kieran, Mark W ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bcl 2; Ependymoma; Ezrin; Microinvasion; MMP14; MMP2

Indexed keywords

ANTINEOPLASTIC AGENT; EZRIN; GELATINASE A; MATRIX METALLOPROTEINASE 14; PROTEIN BCL 2; CYTOSKELETON PROTEIN; TUMOR MARKER;

ADJUVANT THERAPY; ADOLESCENT; ARTICLE; BRAIN SURGERY; CANCER CELL; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; EPENDYMOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR LOCALIZATION; WHITE MATTER; BIOSYNTHESIS; DISEASE FREE SURVIVAL; ENZYMOLOGY; KAPLAN MEIER METHOD; MORTALITY; PATHOLOGY;

CYTOSKELETAL PROTEINS; DISEASE-FREE SURVIVAL; EPENDYMOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 52649177396     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318184f413     Document Type: Article

References (42)

1. Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumors. Tumors of the Nervous System. Lyon, France: IARC Press, 2000
2. Wang M,Wang T,Liu S,et al. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 2003;20:65-72
3. J̈̈linoj̈ J, Herva R, Korpela M, et al. Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms. J Neurooncol 2000;46:81-90
4. Thorns V, Walter GF, Thorns C. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 2003;23:3937-44
5. Weng WH, Ahlén J, Aström K, et al. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 2005;11:6198-204
6. Kim MS, Song WS, Cho WH, et al. Ezrin expression predicts survival in stage IIB osteosarcomas. Clin Orthop Relat Res 2007;459:229-36
7. Park HR, Jung WW, Bacchini P, et al. Ezrin in osteosarcoma: Comparison between conventional high-grade and central low-grade osteosarcoma. Pathol Res Pract 2006;202:509-15
8. K̈bel M, Langhammer T, Ḧttelmaier S, et al. Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas. Mod Pathol 2006;19:581-87
9. Moilanen J, Lassus H, Leminen A, et al. Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecol Oncol 2003;90:273-81
10. Wick W, Grimmel C, Wild-Bode C, et al. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. J Neurosci 2001;21:3360-68
11. Geiger KD, Stoldt P, Schlote W, et al. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 2000;157:1785-93
12. Weller M, Malipiero U, Aguzzi A, et al. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 1995;95:2633-43
13. Wick W, Wagner S, Kerkau S, et al. BCL-2 promotes migration and invasiveness of human glioma cells. FEBS Lett 1998;440:419-24
14. Wild-Bode C, Weller M, Wick W. Molecular determinants of glioma cell migration and invasion. J Neurosurg 2001;94:978-84
15. Rushing EJ, Brown DF, Hladik CL, et al. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. Mod Pathol 1998;11:464-70
16. Zamecnik J, Snuderl M, Eckschlager T, et al. Pediatric intracranial ependymomas: Prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod Pathol 2003;16:980-91
17. Larsen K. Joint analysis of time-to-event and multiple binary indicators of latent classes. Biometrics 2004;60:85-92
18. Tihan T, Zhou T, Holmes E, et al. The prognostic value of histological grading of posterior fossa ependymomas in children: A Children's Oncology Group study and a review of prognostic factors. Mod Pathol 2008;21:165-77
19. Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood: Long-term outcome and prognostic factors. Neurosurgery 1995;37:655-66
20. Sala F, Talacchi A, Mazza C, et al. Prognostic factors in childhood intracranial ependymomas: The role of age and tumor location. Pediatr Neurosurg 1998;28:135-42
21. Bouffet E, Perilongo G, Canete A, et al. Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 1998;30:319-31
22. Figarella-Branger D, Civatte M, Bouvier-Labit C, et al. Prognostic factors in intracranial ependymomas in children. J Neurosurg 2000;93:605-13
23. Giese A, Kluwe L, Laube B, et al. Migration of human glioma cells on myelin. Neurosurgery 1996;38:755-64
24. Giese A, Laube B, Zapf S, et al. Glioma cell adhesion and migration on human brain sections. Anticancer Res 1998;18:2435-47
25. Pedersen PH, Edvardsen K, Garcia-Cabrera I, et al. Migratory patterns of lac-z transfected human glioma cells in the rat brain. Int J Cancer 1995; 62:767-71
26. Amberger VR, Hensel T, Ogata N, et al. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res 1998;58:149-58
27. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996;39:235-52
28. Seiki M. Membrane-type matrix metalloproteinases. APMIS 1999;107: 137-43
29. Ohuchi E, Imai K, Fujii Y, et al. Membrane type 1 matrix metal-loproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-51
30. Kunishio K, Okada M, Matsumoto Y, et al. Matrix metalloproteinase-2 and -9 expression in astrocytic tumors. Brain Tumor Pathol 2003;20: 39-45
31. Guo P, Imanishi Y, Cackowski FC, et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol 2005;166:877-90
32. Hu B, Jarzynka MJ, Guo P, et al. Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 2006;66:775-83
33. Hara A, Hirose Y, Yoshimi N, et al. Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. Neurol Res 1997;19:623-28
34. Nakasu S, Nakasu Y, Nioka H, et al. Bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 1994;88:520-26
35. Schiffer D, Cavalla P, Migheli A, et al. Bcl-2 distribution in neuro-epithelial tumors: An immunohistochemical study. J Neurooncol 1996; 27:101-9
36. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997; 387:773-76
37. Zhang Z, Vuori K, Wang H, et al. Integrin activation by R-ras. Cell 1996;85:61-69
38. Deryugina EI, Luo GX, Reisfeld RA, et al. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res 1997;17:3201-10
39. Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997; 9:701-6
40. Sato N, Funayama N, Nagafuchi A, et al. A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/ plasma membrane association sites. J Cell Sci 1992;103:131-43
41. Hiscox S, Jiang WG. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin. J Cell Sci 1999;112:3081-90
42. Lamb RF, Ozanne BW, Roy C, et al. Essential functions of ezrin in maintenance of cell shape and lamellipodial extension in normal and transformed fibroblasts. Curr Biol 1997;7:682-88